Deligné P
Ann Anesthesiol Fr. 1976;17(9):993-1009.
There is a great deal of evidences (pharmacological, experimental and clinical, therapeutic, biological, biochemical, metabolic, toxicological and neurophysiological) which permits one to characterise among the psychotropic substances, the antineurotic or antipsychotic properties of certain psycholeptic drugs. They authorize also the differentiation in the sub-group of "antipsychotics" of substances with a dominant neuroplegic or neuroleptic activity and others, such as lithium, which do not have this activity. This revision of the terminology avoids the confusion maintained by the use of terms "tranquillisers" and "neuroleptics" in the classification of psychotropic drugs.
有大量证据(药理学、实验和临床、治疗、生物学、生化、代谢、毒理学和神经生理学方面的证据)使人们能够在精神药物中确定某些精神安定药物的抗神经症或抗精神病特性。这些证据还使得能够在“抗精神病药物”亚组中区分出具有主要的神经麻痹或安定作用的物质与其他物质,如锂,锂不具有这种作用。对术语的这种修订避免了在精神药物分类中因使用“镇静剂”和“安定药”这些术语而造成的混淆。